Latest action: Read twice and referred to the Committee on the Judiciary.
Referred to one or more standing committees for review, hearings, and possible markup.
Specific committees not parsed from action data.
The committee may hold hearings, amend the bill, or let it die without action.
Next: Reported
Full chamber floor — Speaker / Majority Leader controls scheduling
Bill regulates pharmacy benefit managers' practices in health insurance.
The problem
Pharmacy benefit managers control drug pricing and access without much oversight. Patients and pharmacies say high costs and unfair practices hurt them.
The proposal
The bill would set new rules on how pharmacy benefit managers operate, including limits on fees and requirements for transparency.
The impact
Patients may pay less for drugs. Pharmacies could see changes in payments. Insurance companies and pharmacy benefit managers face new regulations.
Limits on pharmacy benefit manager fees could reduce what patients pay for medications. People with high prescription costs would save money. This helps families afford necessary medicines.
The bill requires pharmacy benefit managers to explain their pricing decisions. Patients and doctors can better understand why drugs cost what they do. This makes the system fairer.
Small independent pharmacies often struggle with low reimbursement rates from pharmacy benefit managers. Fairer payment rules help local businesses survive and compete.
Clearer rules about which drugs are covered help patients get the medicines their doctors prescribe. Fewer surprises mean better health outcomes.
If pharmacy benefit managers face stricter rules, they may raise insurance costs to stay profitable. Employers and patients could pay more in premiums.
Pharmacy benefit managers negotiate lower drug prices, which helps fund research for new medicines. Stricter rules might reduce these negotiations and slow new drug development.
New regulations create compliance costs for insurance companies. They must hire staff to follow the new rules, which costs money.
New rules might have unforeseen effects on how the drug system works. Some changes could hurt patients instead of help them.
Generated by AI from the bill text. Not a prediction and not legal or policy advice. The percentage is the model's own rating of each item — self-reported, and not a measure of how accurate it is.
Loading map…
Loading...
0 citizens have already voted
Free · No spam · See how your representatives voted
Be the first to weigh in
Your vote starts the conversation
How citizen engagement works
Citizens vote & comment
Public opinion data is aggregated and updated in real time.
Patterns become visible
Representatives can see constituent sentiment broken down by district.
Your voice on the record
Contact your rep directly — one constituent call can shift a staffer's priority list.
Research shows that constituent contacts — especially calls — are among the most effective ways to influence a legislator's position on active bills.
Individual contributions, grouped by employer · FEC
Where their individual donors work · 2026 cycle
Money from people who work there, not from the company. Not tied to this bill.
Itemized individual contributions via FEC, grouped by the employer each contributor self-reported. Companies and unions cannot contribute to federal candidates from their treasuries, so these totals are money from people who work at an employer — never from the organization itself. They are campaign contributions covering a full election cycle and are not connected to this bill.
Senate LDA lobbying disclosures
Couldn't load lobbying disclosures right now.